Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Alexion Pharmaceuticals Inc. (ALXN)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ALXN
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
21 Breakout Stocks to Watch, And How to Generate Income with Apple LEAP Options
Oct 23
•
Marco Hickey
•
1 Comment
Pundits Are Wrong: Healthcare Reform Will Increase Profits
Sep 17
•
Todd Campbell
•
24 Comments
Ken Griffin's Citadel Fund: Options Eye Candy
Sep 10
•
Market Folly
•
2 Comments
38 Reasons the Google IPO Isn't the Big Deal Some Are Making It Out to Be
Aug 19
•
Bespoke Investment Group
•
12 Comments
Breakout Stocks on Huge Volume: Three Option Trades
Jul 27
•
Marco Hickey
•
4 Comments
Biotech ETFs Surge Again on M&A News
Jul 24
•
Michael Johnston
•
Comment!
Wall Street Breakfast: Must-Know News
Jul 23
•
SA Editor Rachael Granby
•
18 Comments
15 Necessary Components for the Next Leg Higher
Jul 21
•
The Inflection Point
•
5 Comments
Is IBB the Best Biotech ETF?
Jul 2
•
Don Dion
•
1 Comment
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
Jun 28
•
Marco Hickey
•
1 Comment
Wall Street Breakfast: Must-Know News
Apr 23
•
SA Editor Rachael Granby
•
9 Comments
Where Might Genentech Investors Redeploy $47B?
Mar 16
•
Michael Becker
•
2 Comments
Reversal of Stem Cell Research Ban: 13 Stocks to Benefit
Mar 12
•
Brian Dean
•
9 Comments
12 Stem Cell Stocks - Updated
Mar 9
•
Stockerblog
•
8 Comments
Biopharma: Instead of M&A, Think P&A
Mar 4
•
Mike Huckman
•
2 Comments
IBB: Newfound Stability Lures Biotech Investors
Feb 18
•
Don Dion
•
Comment!
I Like Haemonetics While Cognizant and Alexion Breed Concern
Feb 16
•
Robert Freedland
•
Comment!
Wall Street Breakfast: Must-Know News
Feb 12
•
SA Editor Rachael Granby
•
14 Comments
Hedge Fund Portfolio Tracking: Citadel Investment Group (Ken Griffin), Q3 2008
Jan 13
•
Market Folly
•
6 Comments
Hedge Fund Tracking: Pequot Capital Management (Art Samberg), Q3 2008
Dec 30, 2008
•
Market Folly
•
Comment!
Even Fatter Yields for Pfizer; M&A Targets in the Sector
Oct 17, 2008
•
Mike Havrilla
•
3 Comments
Stocks Potentially Impacted by SEC's Enforcement of Regulation SHO
Sep 18, 2008
•
J Clinton Hill
•
6 Comments
5 Potential Buyout Targets in Biotech - Barron's
Aug 17, 2008
•
SA Editor Rachael Granby
•
9 Comments
Tuesday Options Outlook: MER, C, CSC, TIE, PWAV, GPS, ALXN, ELNK
Jul 29, 2008
•
Andrew Wilkinson
•
Comment!
A Biotech Bloom in July
Jul 28, 2008
•
Option Dragon
•
10 Comments
Biotech Buying Binge About to Begin?
Jul 23, 2008
•
Mike Havrilla
•
3 Comments
Q1 Earnings 'Triple Plays'
Jul 9, 2008
•
Bespoke Investment Group
•
5 Comments
Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?
May 9, 2008
•
Don Dion
•
1 Comment
Alexion Pharma: Bounce Play?
Feb 21, 2008
•
Notable Calls
•
Comment!
Top 7 BioPharma & Pharma Innovations of 2007
Dec 17, 2007
•
Fredric Cohen, M.D.
•
1 Comment
Nine Stem Cell Stocks to Add to Your Portfolio
Oct 2, 2007
•
Stockerblog
•
2 Comments
Companies With The Most Analyst Attention & Affection
Jun 5, 2007
•
Bespoke Investment Group
•
3 Comments
Loeb's Third Point Releases 13F Filing, Shows a Number of New Positions
May 17, 2007
•
Lon Juricic
•
Comment!
Alexion Pharmaceuticals: Costs of Healthcare Rise to the Extreme
Mar 30, 2007
•
Chad Brand
•
Comment!
Conference Call With Alexion Leaves Credit Suisse Analyst Speechless
Mar 28, 2007
•
Fredric Cohen, M.D.
•
1 Comment
Biotech Day in Review: AtheroGenics Tumbles on Drug Test Failure
Mar 20, 2007
•
Centient Biotech Investor
•
Comment!
Investing in Stem Cell Stocks: Growth Industry of the Future?
Feb 21, 2007
•
Stockerblog
•
12 Comments
Chart: Biotech Stocks - Annual Earnings Growth
Jul 27, 2006
•
Robert Zenilman
•
Comment!
Chart: Biotech Stocks - Quarterly Earnings Growth
Jul 20, 2006
•
Robert Zenilman
•
Comment!
Chart: Biotech Stocks - Annual Revenue Growth (Last 12 Months Reported)
Jul 13, 2006
•
Robert Zenilman
•
Comment!
Chart: Biotech Stocks - Quarterly Revenue Growth
Jul 6, 2006
•
Robert Zenilman
•
Comment!
1
2
Next Page